HUE026468T2 - A spiramicinek bioszintézisében részt vevõ polipeptidek, a polipeptideket kódoló nukleotid-szekvenciák és alkalmazásaik - Google Patents

A spiramicinek bioszintézisében részt vevõ polipeptidek, a polipeptideket kódoló nukleotid-szekvenciák és alkalmazásaik Download PDF

Info

Publication number
HUE026468T2
HUE026468T2 HUE07019306A HUE07019306A HUE026468T2 HU E026468 T2 HUE026468 T2 HU E026468T2 HU E07019306 A HUE07019306 A HU E07019306A HU E07019306 A HUE07019306 A HU E07019306A HU E026468 T2 HUE026468 T2 HU E026468T2
Authority
HU
Hungary
Prior art keywords
gene
fee
sequence
cassette
strain
Prior art date
Application number
HUE07019306A
Other languages
English (en)
Inventor
Marie-Helene Blondelet-Rouault
Helene Dominguez
Emmanuelle Darbon-Rongere
Claude Gerbaud
Anne Gondran
Fatma Karray
Patricia Lacroix
Nathalie Oestreicher-Mermet-Bouvier
Jean-Luc Pernodet
Karine Tuphile
Original Assignee
Aventis Pharma Sa
Centre Nat De La Rech Scient (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0212489A external-priority patent/FR2845394A1/fr
Priority claimed from FR0302439A external-priority patent/FR2851773A1/fr
Application filed by Aventis Pharma Sa, Centre Nat De La Rech Scient (Cnrs) filed Critical Aventis Pharma Sa
Publication of HUE026468T2 publication Critical patent/HUE026468T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Claims (4)

  1. Szafeadalpp âgénypestok I* A spksmæmek Moszîiiîëzissber! téSÂksevë pel%>«piide£ kddoto pcdiriiddeobd- äzzsi iüpjjg^ s sôMs#ispyi tüfteppsl&s JstetSvd tPszi & $.piramk'ln«d£ ISTmiltHeBek nôvekedését ês àïssai, lôgjr a polbïukisoîid ssd;Yt'sciéja: |g|?.»,Â31> NO Iï l vagy: Î41 szsmdi szekvsssiäk sgyiks, {!>} oly&o pobatikleodd, -spyelf tegaiÄ |0%, 85%, 90%. 95% v3gy 985b D«ide^jg^aoss%ei mutai a* (a) szerimi polinukleotiddal. I. Az L. igegyponk samrid. pslßiiktetid. aæss! JÂæsepe, fe»gÿ ssppskségbPl :szlppip:0 bakiénambô! van izolaiva. % &spfeajs*a««& bloszfôtszisébeis sfe w6 polipepdd, azzsd Jei&i&ezv«, tegy a tuSisnseiPse 'Mt&MMé îsszl: a ispîtaâsfeïsek bîiasïe^séâuïk advdiedésO as szz&l, bpgy apelipéptid szpkvmkdlia: (a) sdEÇIlO NO Π2 vagy 142 szermn szekvesciilkegyike, Cb) olyaâ pöbpepÄ 3ίίκΝ tegallbh: ÜG%, 85%, 9Ä $5% vagy 98%: amiaosa^azoaoxsagot mutât m %*} szeratii poipeptsddei. 4 A 3, igêîîypoSî szertmi poHpepiid. azzal jelfemerve, à»gy a szekveseùya a SEQ iD NO i 12 vagy 142 szedad szekvesiîidî îariabsazza. 5, A 3. igêîsypost szsdnb pebpepdil azzaî jdJeraeæv®* begy $&êpimt$êm xmnwm£0ti$ saärmazö baktériùïîîbôl vaxi izolalva.
  2. 6, Exptevs.zK>s vekïor, azzal |*Îé«»8sïy«,; tegy fbgailbb figyg i 3.,. 4>:: vagy 5; igépypaaï: :sz«dad ppipspudet kôdokS nukleinsav-szek^sßCJät iaftalm^K. %Pazilasipï,; axseiy megfelslb sxpresazîdsvekiortiadateaz, as&amp;sly fskatpvdlasglpgy vagy 0M,ia 3., 4. vagy 5. IgpîXypxiri· «.zerind palipupHd expiresxziôjàï. 8. A 7, ïgêîiyposî szeppti g&amp;zdaseîk Jeße«sezv«s feogy gseteiét* gîizdasejtek ès tstoiéiâ gaaaks^tefcMzGÎ vas» ksvaiiasztva. 9. A 8. igénypont szerâsri gazdaseji, azzal jelkßöazve, hsgy E. coïE vovarxejtek, élesztô xajtc-k é.t emlës sejtak kôzüi van kivâiasztva. iÔ. A (gésiypora szerint? gaxiaxejt ansdybß kgaÄb egy. az L vagy 2. îgéiiypômb&amp;H deimiâk polmpktebd «»'vagy kgaMbb egy b;, igéaypsafc szeriad expresszïda vektof leit txxèpitv«. SîÆJMs· a 1-5- %ê?xypOô*ôk Müîïtelÿikô szetidfi polâpepdd eloalbiasâm, azzal feiefttezvg, lïégy az elszaSip^gilbaB fbglaljaa: kôvàtezè ^pesôkdt:; a| apôlipeptidei ké>dôk> Îegalàbb egy xvakkdnvijvfebitkxszidsdt Ebegfciiio vgktorba; li|i àz <t) bkpës szsrmti vekitxral trasazfetmdii: vagy itfsasæM gazdasejt teôÿésziésdi: megîdlaiS tenyésztô tàpkô/eglx;n; c) s kondicionàk lenvdszté ïàpkdzsg vagy .scjt-exirakiimt vxasx<ax;yc'rését; da a poiipspîtd dM^asztâsàt és stegîisztiiâââta e) ïepekbea kapott teßvesp^ ^pkbzegbô! yagy tnasképpen a ^^«stedipppbd!; «} szüfcxèg szermt a termed rekombinäns poilpeptid jtekmzêséî. IS.- As l. vagy 2 . ^x&amp;pommsmÜ pëtimiiâ&amp;^tâ.*SæWmÊs&amp; mÊm&amp;fâsammm· *piœmm&amp; immMsmek javMséra.
  3. 13. Spirarfiiclfl-îenssU> musclas mikroorgasxizmus, a*?.sl Jelfesôïesv®, bogy taUmnel icgaiâbb egy oly&amp;n kôifolè .szslîvssdâi, amely 1. vagy 2, Igéaypeæî szeribtî szàsm^iM taartatagz, vagy olyaa kèfeM «ïiakvpJÂ, amely 3.. 4. vagy 5. igényporu s^eriap,poljg8p^d«kfeôdei a kérdé.ses kôdolo sxekvstKiâ rùlterntelése xpiramkm-tefcpslê mlkipergasbissuis ik lgésiyp>nî szerluis eypsasaziPs yektorral: vm MsdPvé tèm a. kôdolô: :szskvsscia tâitenîîslésët 34, 3:3:. igsRypoai: szeribli maîsas HîikrotagpHKâïsas, azzal JæHgôîeasvej bogy a: léltertsd egy vagy ii>bb kryplô saekyeßeiäi, asxusly m L igsisypealbaft Ifeîla göinoldeQiid-isxskßPsciäk egyiksi tartalmazza. 15. Λ 13. vagy 34. sgèaypoai szerinu mutans mlayprgasimua, azzal ieltemexve, lisgy a salkfBöfgaxßpsas sxesmsctsdgPe îpfeasé feaMfekm S 6. A 13., 14. vagy 15. tgénypont szermis mutaas roxkrisorgcimxmus. azzal jelteinezve, ®pgy a mikKyàïgpagpas S. wvê^iemm :1¾ E|âfâs s**»ï jdfemezv®, b»gy tnagäPaß fögla|jä a kövdkezö lépéseket: (a) a 13-16. sgénypomok Mrmdys'ke szerinti m ikroorgasiztnus ienyésztdxét a roegfelefô tenyésztô tapkâzegben, h) a kondidonàlt PïRyészîè tàpkôzeg vagy se|feextraktum yfezapypéséî, «> a teæselt spîipsic&amp;ek eîvalaszksàt es îasglisztdâsat a b) lépéi&amp;sîii kapoit teayéâztiëtäpközsgbpi: vagy msskpppan a sejt^xtfakajgpMl
  4. 18. Strepiomycas an^ß&amp;mS; törzs, gazai jdlemezve* ls©gy sz a ôS€23pÉI?M75|2:|: Idas,, amsly depfiiïâlva lest « Collection f%ôox!afe da Cultures <le Slkroorg&amp;tosmes (CNCM) imézsteél Imksmtgmmsm îaRyéSXëtek tsetsmei gyûjiemény«]. Institut Pasteur. 25. mt du Doctestr Roux 35724 Pans Cedes 1S,; Fraaplaprszäg etase* ·20»3. Oktober fc-àn az 1 -3101 regkztrâdôs: sæcim alatt. If. Eprâs xpirarïdcnpek} îctrodésére, arzal |dtem«æve, bogy tnagciba® iogläfla a kôvetkezé lépésekeî. ^ai a 18. ïgèsypôôt szensii Mkroorganizisvas tenyésztését a megf'cidô tenyésziô tâpkSkdgliep. b) a koïidiclonàit tenvéseto Säpközeg vagy sejtextrakmtn visszaayettäsdE ç) a spiraraiciask elvàlasztâséa: és spagiisztpsat a b) fepéslpp. kapott te-mkztà îâpkôzagbdl vagy iudsk^jpen a SÎgPiâxixakPtixï3>ôL
HUE07019306A 2002-10-08 2003-10-08 A spiramicinek bioszintézisében részt vevõ polipeptidek, a polipeptideket kódoló nukleotid-szekvenciák és alkalmazásaik HUE026468T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0212489A FR2845394A1 (fr) 2002-10-08 2002-10-08 Polypeptides impliques dans la biosynthese des spiramycines, sequences nucleotidiques codant ces polypeptides et leurs applications
FR0302439A FR2851773A1 (fr) 2003-02-27 2003-02-27 Polypeptides impliques dans la biosynthese des spiramycines, sequences nucleotidiques codant ces polypeptides et leurs applications
US49349003P 2003-08-07 2003-08-07

Publications (1)

Publication Number Publication Date
HUE026468T2 true HUE026468T2 (hu) 2016-05-30

Family

ID=36114221

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07019306A HUE026468T2 (hu) 2002-10-08 2003-10-08 A spiramicinek bioszintézisében részt vevõ polipeptidek, a polipeptideket kódoló nukleotid-szekvenciák és alkalmazásaik

Country Status (6)

Country Link
US (1) US7579167B2 (hu)
DK (1) DK1905833T3 (hu)
ES (1) ES2552912T3 (hu)
HK (1) HK1122330A1 (hu)
HU (1) HUE026468T2 (hu)
RU (1) RU2377304C2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101914482B (zh) * 2010-07-23 2012-07-04 中国医学科学院医药生物技术研究所 一株异戊酰螺旋霉素i组分高含量、高产量基因工程菌
US10577594B2 (en) 2015-07-24 2020-03-03 Novozymes, Inc. Polypeptides having arabinofuranosidase activity and polynucleotides encoding same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068189A (en) 1988-05-13 1991-11-26 Eli Lilly And Company Recombinant dna vectors encoding a 4"-o-isovaleryl acylase derived from a carbomycin biosynthetic gene, designated care, for use in streptomyces and other organisms
JP2749616B2 (ja) 1988-05-24 1998-05-13 メルシャン株式会社 マクロライド抗生物質の4”位アシル化酵素をコードする遺伝子
US5098837A (en) 1988-06-07 1992-03-24 Eli Lilly And Company Macrolide biosynthetic genes for use in streptomyces and other organisms
US5322937A (en) 1990-06-01 1994-06-21 Mercian Corporation Genes encoding a 3-acylation enzyme for macrolide antibiotics
US5514544A (en) 1991-07-26 1996-05-07 Eli Lilly And Company Activator gene for macrolide biosynthesis
CA2197160C (en) 1996-02-22 2007-05-01 Stanley Gene Burgett Platenolide synthase gene
CA2197524A1 (en) 1996-02-22 1997-08-22 Bradley Stuart Dehoff Polyketide synthase genes
EP1032679A2 (fr) 1997-07-25 2000-09-06 Hoechst Marion Roussel Genes de biosynthese et de transfert des 6-desoxyhexoses chez saccharopolyspora erythraea et chez streptomyces antibioticus et leur utilisation
AU2002355157A1 (en) 2001-07-26 2003-02-17 Ecopia Biosciences Inc. Genes and proteins for the biosynthesis of rosaramicin

Also Published As

Publication number Publication date
DK1905833T3 (en) 2015-11-23
US7579167B2 (en) 2009-08-25
RU2005113874A (ru) 2006-02-27
HK1122330A1 (en) 2009-05-15
ES2552912T3 (es) 2015-12-03
RU2377304C2 (ru) 2009-12-27
US20050202528A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
Courtois et al. Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products
Claesen et al. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides
Janso et al. Biosynthetic potential of phylogenetically unique endophytic actinomycetes from tropical plants
EP1366176B1 (fr) Genes synthetiques et plasmides bacteriens depourvus de cpg
McGregor et al. Report of the cyanotoxins cylindrospermopsin and deoxy-cylindrospermopsin from Raphidiopsis mediterranea Skuja (Cyanobacteria/Nostocales)
KR101647843B1 (ko) 변형된 서열을 갖는 레오바이러스
AU2005211587A1 (en) Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds
EP3011828A1 (en) Endophytes and related methods
JPH06502309A (ja) 効率的抑制遣伝子要素のための方法および用途
JP2021501595A (ja) 遺伝子改変バチルス・サブティリス(Bacillus subtilis)株、最適化されたベクター、及びその使用
JP2010539994A5 (hu)
Guo et al. Mutations that disrupt either the pqq or the gdh gene of Rahnella aquatilis abolish the production of an antibacterial substance and result in reduced biological control of grapevine crown gall
CN106754608B (zh) 生产米尔贝霉素的重组链霉菌及其制备方法和应用
Mullins et al. Discovery of the Pseudomonas polyyne protegencin by a phylogeny-guided study of polyyne biosynthetic gene cluster diversity
Liang et al. Systematic identification of pathogenic Streptomyces sp. AMCC400023 that causes common scab and genomic analysis of its pathogenicity island
Lu et al. Global and pathway-specific transcriptional regulations of pactamycin biosynthesis in Streptomyces pactum
Kimura et al. Characterization of zoospore type IV pili in Actinoplanes missouriensis
CN108753674B (zh) 一种调控米尔贝霉素合成的基因簇、重组链霉菌及其制备方法和应用
CN102321647B (zh) 一种β-葡萄糖苷酶、编码基因、载体、工程菌及其应用
HUE026468T2 (hu) A spiramicinek bioszintézisében részt vevõ polipeptidek, a polipeptideket kódoló nukleotid-szekvenciák és alkalmazásaik
Ji et al. Application of FLP-FRT system to construct unmarked deletion in Helicobacter pylori and functional study of gene hp0788 in pathogenesis
CN112409372B (zh) 玉红霉素类似物、制备方法及其应用
Rosellini et al. Kanamycin-resistant alfalfa has a point mutation in the 16S plastid rRNA
CN108753799B (zh) 一种米尔贝霉素合成正调控基因kelR、编码蛋白、基因工程菌及其制备方法和应用
EP1686947A2 (en) Method for the production of bioactive substances from the novel actinomycete taxon mar2 (marinophilus)